{"id":48421,"date":"2022-09-15T13:01:58","date_gmt":"2022-09-15T11:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/"},"modified":"2022-09-15T13:01:58","modified_gmt":"2022-09-15T11:01:58","slug":"diality-names-pamela-wapnick-as-chief-financial-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/","title":{"rendered":"Diality Names Pamela Wapnick as Chief Financial Officer"},"content":{"rendered":"
\n

\nWapnick brings decades of financial experience to the company as it prepares for commercialization of its smart, mobile hemodialysis platform<\/i><\/b>\n<\/p>\n

IRVINE, Calif.–(BUSINESS WIRE)–Diality<\/a> Inc., a medical technology company developing a smart, mobile hemodialysis platform, today announced the hiring of Pamela Wapnick as chief financial officer. She brings to the company more than 30 years of highly diversified financial experience, primarily in the biotech and pharmaceutical industries, as it readies for the commercial launch of its technology in 2023.\n<\/p>\n

<\/a><\/p>\n

\nWapnick\u2019s career history includes tenure at Amgen Corp. (NSDQ:AMGN), where she served as both vice president of finance for R&D and vice president and treasurer. In those positions, she led the spending decision process for Amgen\u2019s $3 billion R&D budget, and raised more than $6 billion in financing. She then served as CFO at True North Therapeutics and, later, at Graybug Vision. At True North, she raised $45 million in Series D financing, and led the preparation for an initial public offering prior to the company\u2019s sale to Bioverativ. At Graybug Vision, Wapnick raised $55 million in Series C financing, and completed multiple audits. Most recently, she served as CFO at Capsida Biotherapeutics, where she built several functions of the company from startup to over 100 employees. Wapnick holds a BA in Economics from Wellesley College and an MBA from Columbia University.\n<\/p>\n

\nDiality is developing a smart hemodialysis platform designed to be as powerful and flexible as in-center treatment, in a small, easy-to-use device. Intended to be safe to operate in any environment, the Diality system\u2019s versatility allows healthcare providers to tailor treatment to each patient\u2019s specific needs regardless of care setting. Its compact footprint and mobility are intended to enable it to be easily integrated into \u2013 and transported within \u2013 any dialysis setting, be it acute-care hospital, dialysis clinic, transitional care unit, traditional home, or skilled nursing facility.\n<\/p>\n

\n\u201cPam is a proven leader with decades of financial and fundraising expertise, both in the private sector and in the capital markets,\u201d said Dr. Osman Khawar, chief executive officer at Diality. \u201cHer extensive experience in the life sciences industry will be invaluable as we look to change the standard of care for dialysis patients.\u201d\n<\/p>\n

\nWapnick added, \u201cI was immediately intrigued by Diality\u2019s elegant and innovative approach to mobile hemodialysis and plans to come to market in 2023. I share our team\u2019s dedication to the company\u2019s mission of developing solutions that improve lives impacted by kidney disease.\u201d\n<\/p>\n

\nAbout Diality<\/b>\n<\/p>\n

\nDiality is a medical technology company developing a smart hemodialysis platform designed to be as powerful and flexible as in-center treatment, in a small, easy-to-use device that\u2019s intended to be safe to operate in any environment, with enough versatility to allow healthcare providers to tailor treatment to each patient\u2019s specific needs. The Diality system\u2019s compact footprint and mobility are intended to enable it to be easily integrated into \u2013 and transported within \u2013 any dialysis setting, be it acute-care hospital, dialysis clinic, transitional care unit, traditional home, or skilled nursing facility. To learn more, please visit www.diality.com<\/a> or find us on LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSam Choinski
\n
Pazanga Health Communications<\/a>
schoinski@pazangahealth.com<\/a>
(860) 301-5058\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Wapnick brings decades of financial experience to the company as it prepares for commercialization of its smart, mobile hemodialysis platform IRVINE, Calif.–(BUSINESS WIRE)–Diality Inc., a medical technology company developing a smart, mobile hemodialysis platform, today announced the hiring of Pamela Wapnick as chief financial officer. She brings to the company more than 30 years of … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48421","6":"format-standard","7":"category-industry"},"yoast_head":"\nDiality Names Pamela Wapnick as Chief Financial Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diality Names Pamela Wapnick as Chief Financial Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Wapnick brings decades of financial experience to the company as it prepares for commercialization of its smart, mobile hemodialysis platform IRVINE, Calif.–(BUSINESS WIRE)–Diality Inc., a medical technology company developing a smart, mobile hemodialysis platform, today announced the hiring of Pamela Wapnick as chief financial officer. She brings to the company more than 30 years of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-15T11:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220915005207\/en\/1572202\/21\/Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Diality Names Pamela Wapnick as Chief Financial Officer\",\"datePublished\":\"2022-09-15T11:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/\"},\"wordCount\":535,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915005207\\\/en\\\/1572202\\\/21\\\/Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/\",\"name\":\"Diality Names Pamela Wapnick as Chief Financial Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915005207\\\/en\\\/1572202\\\/21\\\/Logo.jpg\",\"datePublished\":\"2022-09-15T11:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915005207\\\/en\\\/1572202\\\/21\\\/Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220915005207\\\/en\\\/1572202\\\/21\\\/Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diality-names-pamela-wapnick-as-chief-financial-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diality Names Pamela Wapnick as Chief Financial Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diality Names Pamela Wapnick as Chief Financial Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/","og_locale":"en_US","og_type":"article","og_title":"Diality Names Pamela Wapnick as Chief Financial Officer - Pharma Trend","og_description":"Wapnick brings decades of financial experience to the company as it prepares for commercialization of its smart, mobile hemodialysis platform IRVINE, Calif.–(BUSINESS WIRE)–Diality Inc., a medical technology company developing a smart, mobile hemodialysis platform, today announced the hiring of Pamela Wapnick as chief financial officer. She brings to the company more than 30 years of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-15T11:01:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220915005207\/en\/1572202\/21\/Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Diality Names Pamela Wapnick as Chief Financial Officer","datePublished":"2022-09-15T11:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/"},"wordCount":535,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220915005207\/en\/1572202\/21\/Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/","url":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/","name":"Diality Names Pamela Wapnick as Chief Financial Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220915005207\/en\/1572202\/21\/Logo.jpg","datePublished":"2022-09-15T11:01:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220915005207\/en\/1572202\/21\/Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220915005207\/en\/1572202\/21\/Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/diality-names-pamela-wapnick-as-chief-financial-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Diality Names Pamela Wapnick as Chief Financial Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48421"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48421\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}